Wegovy tablets: daily routine, safety and injection differences

At a glance

Wegovy tablets contain semaglutide and are taken daily, rather than injected weekly. They require a specific fasting routine. They are prescription-only and need assessment and ongoing review. Choosing between formulations involves your health, other medicines and daily routine; neither is automatically the right option because it avoids or reduces injections.

Are Wegovy tablets approved in the UK?

The MHRA authorised Wegovy tablets in June 2026 for weight loss and weight maintenance in adults with obesity, or overweight with a weight-related condition, alongside a reduced-calorie diet and increased physical activity. The licensed BMI thresholds are at least 30, or at least 27 with an associated condition. A prescriber still needs to assess individual suitability.

What changes compared with the injection?

Both formulations contain semaglutide, but their doses, administration and routines differ. Tablets are taken daily; injections are taken weekly. Tablet milligrams cannot simply be exchanged for injection milligrams. Do not combine formulations or switch yourself.

The practical question is which routine you can follow safely and consistently. Before an appointment, write down when you wake, eat breakfast, drink coffee and take medicines. This helps identify conflicts that might otherwise be missed in a discussion focused only on needle preference.

How are Wegovy tablets taken?

The UK patient leaflet explains the routine:

1. Take on an empty stomach after at least eight hours of fasting.
2. Swallow whole with a sip of water, up to 120 mL.
3. Wait at least 30 minutes before food, drink or other oral medicines.

Follow your own prescription and leaflet. Ask a pharmacist to plan the timing of other morning medicines rather than moving them yourself. If a tablet dose is missed, the leaflet advises skipping it and taking the usual dose the following day.

How is the dose reviewed?

The MHRA describes gradual increases from 1.5 mg daily through 4 mg and 9 mg to 25 mg, with at least one month at each level. This is background information, not a personal schedule. Only change the dose when your prescriber directs you.

At review, discuss the routine you actually followed, symptoms, food and fluid intake, and progress. If a fasting window is repeatedly difficult, say so. The useful response is to review the plan together, rather than compensate with extra tablets.

What safety issues need discussing?

Nausea, diarrhoea, constipation and vomiting can occur. Persistent symptoms need clinical advice. Stop taking the medicine and seek urgent help for severe, lasting abdominal pain, which may indicate pancreatitis. Call 999 for breathing problems or swelling of the face or throat.

Tell your clinician about all medicines, diabetes, eye problems, digestive conditions, surgery plans, pregnancy plans and breastfeeding. Do not use during pregnancy or breastfeeding; planned pregnancy needs advance advice. Read the full patient leaflet for precautions and side effects.

Frequently asked questions

Can I switch directly from injections?

A switch needs a prescriber-led plan. Take your current treatment name, formulation, dose and last administration date to the assessment.

Is this the same as Rybelsus?

Rybelsus also contains semaglutide but is a separate medicine used for type 2 diabetes. Do not substitute it yourself. See the NHS semaglutide overview.

Can I take the tablet with breakfast?

No. The fasting and waiting instructions are important for absorption.

Key takeaways

Check the formulation, keep an accurate medication list, and agree a routine and review plan. A daily tablet still requires clinical oversight. Read about Puri Pharmacy’s weight-management assessment and ongoing support for information about the service.